1st Line Pembrolizumab in Treatment of Stage IV NSCLC Patients – A Pattern of Failure Analysis with Associated Survival Outcomes

التفاصيل البيبلوغرافية
العنوان:	1st Line Pembrolizumab in Treatment of Stage IV NSCLC Patients – A Pattern of Failure Analysis with Associated Survival Outcomes
المؤلفون:	All, S., Rashdan, S., Gerber, D.E., Hughes, R., Lohrey, J., Dowell, J., Westover, K.D., Vo, D.T., Iyengar, P.
المصدر:	In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:e360-e360
قاعدة البيانات:	ScienceDirect

كن أول من يترك تعليقا!